Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeNON PROFITACC Cardio-oncology Course Aims to Advance Cardiovascular Care of Cancer Patients, Survivors

ACC Cardio-oncology Course Aims to Advance Cardiovascular Care of Cancer Patients, Survivors

January 21, 2021

ACC Cardio-oncology Course: The American College of Cardiology will host the annual Advancing the Cardiovascular Care of the Oncology Patient Virtual course with live sessions on Feb. 5-6, 2021, and on demand content. The course will feature cardiology and oncology experts providing clinically relevant, best practice strategies for a multidisciplinary team regarding the assessment, diagnosis and management of cardiovascular concerns for cancer patients, as well as those requiring survivorship care.

ACC Cardio-oncology Course co-directors Ana Barac, MD, Ph.D., FACC, and Bonnie Ky, MD, MSCE, FACC, have invited respected experts in the field to create a course covering relevant and required content for both the novice and advanced practitioner. The conference aims to provide participants with the tools needed to improve patient care in their everyday practice in this rapidly evolving field through describing the evolving advances in immunotherapy and the associated cardiotoxicity; defining cardiovascular complications in cancer patients that are specific to coronary disease, vascular disease and bleeding; applying evidence-based strategies for short- and long-term surveillance; and establishing interprofessional cardio-oncology care teams and a framework to improve overall cardiovascular care of cancer patients and survivors.

Sessions Include:

  • Immune Therapy and Cardiovascular Risk
  • Adult and Pediatric Cancer Survivorship: Management of Modifiable Cardiovascular Risk Factors
  • All About Amyloidosis

The course will also feature on-demand content available beginning on Monday, January 25, 2021.

Posters

The following abstracts are a selection of the posters being presented. All ACC Advancing the Cardiovascular Care of the Oncology Patient abstracts are embargoed until Monday, Jan. 25, 2021 at 8 a.m. ET.

  • Cardiovascular Outcomes Associated with Chemotherapy and Targeted Therapies in Adolescent and Young Adult Cancer Survivors
  • Cardiovascular Risk Factors and Comorbidities in Male Breast Cancer Patients (press release available)
  • Risk of Cardiotoxicity with Dual Human Epidermal Receptor (HER2) Targeted Therapies in Breast Cancer
  • The Association of Physical Activity, Cardiac and Patient-Reported Outcomes in HER2+ Breast Cancer Survivors During Therapy
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy